Newly diagnosed chronic granulomatous disease in a 53-year-old woman with Crohn disease

Annals of Allergy, Asthma and Immunology

Volumn 95, Issue 2, 2005, Pages 204-209

  Ramanuja, Srinivasan ^a   Wolf, Karen M ^a   Sadat, Mohammed A ^a   Mahoney, Stephen J ^b   Dinauer, Mary C ^a   Nelson Jr , Robert P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Gastroenterology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; NITROBLUE TETRAZOLIUM; OXIDOREDUCTASE; PORIN; PORIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BURKHOLDERIA CEPACIA; CASE REPORT; CROHN DISEASE; ESCHERICHIA COLI; FEMALE; GRANULOMATOSIS; HUMAN; LIVER ABSCESS; LOBECTOMY; PHAGOCYTE; PNEUMONIA; PRIORITY JOURNAL; RECURRENT INFECTION; SACCHAROMYCES CEREVISIAE; WESTERN BLOTTING;

EID: 23844499127     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61212-4     Document Type: Article

References (40)

1. Berendes H, Bridges RA, Good RA. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med. 1957;40:309-312.
2. Liese JG, Jendrossek V, Jansson A, et al. Chronic granulomatous disease in adults. Lancet. 1996;347:220-223.
3. Quie PG. Chronic granulomatous disease of childhood. Adv Pediatr. 1969;16:287-300.
4. Quie PG, White JG, Holmes B, et al. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest. 1967;46:668-679.
5. Baehner RL, Nathan DG. Leukocyte oxidase: defective activity in chronic granulomatous disease. Science. 1967;155:835-836.
6. Sandborn WJ. Serologic markers in inflammatory bowel disease: state of the art. Rev Gastroenterol Disord. 2004;4: 167-174.
7. Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood: the clinical, pathological, and laboratory features of a new syndrome. AMA J Dis Child. 1959;97: 387-408.
8. Jansz A, Huber J. Fatal granulomatous disease of childhood. Lancet. 1967;1:844-845.
9. Quie PG, Kaplan EL, Page AR, et al. Defective polymorphonuclear-leukocyte function and chronic granulomatous disease in two female children. N Engl J Med. 1968;278:976-980.
10. Holmes B, Quie PG, Windhorst DB, et al. Fatal granulomatous disease of childhood: an inborn abnormality of phagocytic function. Lancet. 1966;1:1225-1228.
11. Macfarlane PS, Speirs AL, Sommerville RG. Fatal granulomatous disease of childhood and benign lymphocytic infiltration of the skin (congenital dysphagocytosis). Lancet. 1967;1: 408-410.
12. Holmes B, Page AR, Good RA. Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest. 1967;46:1422-1432.
13. Quie PG. Chronic granulomatous disease of childhood: a saga of discovery and understanding. Pediatr Infect Dis J. 1993;12: 395-398.
14. Kaplan EL, Laxdal T, Quie PG. Studies of polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood: bactericidal capacity for streptococci. Pediatrics. 1968;41:591-599.
15. Allen RC, Stjernholm RL, Steele RH. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun. 1972;47:679-684.
16. Mills EL, Rholl KS, Quie PG. X-linked inheritance in females with chronic granulomatous disease. J Clin Invest. 1980;66: 332-340.
17. Smith RM, Curnutte JT. Molecular basis of chronic granulomatous disease. Blood. 1991;77:673-686.
18. Clark RA, Malech HL, Gallin JI, et al. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N Engl J Med. 1989;321:647-652.
19. Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine. 2000;79:155-169.
20. Lekstrom-Himes JA, Gallin JI. Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med. 2000;343: 1703-1714.
21. Jirapongsananuruk O, Malech HL, Kuhns DB, et al. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay. J Allergy Clin Immunol. 2003;111:374-379.
22. Zach TL, Quie PG. Prostatitis in chronic granulomatous disease. Am J Med. 1989;87:353-354.
23. Aliabadi H, Gonzalez R, Quie PG. Urinary tract disorders in patients with chronic granulomatous disease. N Engl J Med. 1989;321:706-708.
24. Payne NR, Hays NT, Regelmann WE, et al. Growth in patients with chronic granulomatous disease. J Pediatr. 1983;102: 397-399.
25. Rosenzweig SD, Holland SM. Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol. 2004;113: 620-626.
26. Mansharamani N, Balachandran D, Delaney D, et al. Lung abscess in adults: clinical comparison of immunocompromised to non-immunocompromised patients. Respir Med. 2002;96: 178-185.
27. Kaye MG, Fox MJ, Bartlett JG, et al. The clinical spectrum of Staphylococcus aureus pulmonary infection. Chest. 1990;97: 788-792.
28. Senecal JL, St-Antoine P, Beliveau C. Legionella pneumophila lung abscess in a patient with systemic lupus erythematosus. Am J Med Sci. 1987;293:309-314.
29. Franquet T, Gimenez A, Roson N, et al. Aspiration diseases: findings, pitfalls, and differential diagnosis. Radiographics. 2000;20:673-685.
30. Lukela M, DeGuzman D, Weinberger S, et al. Clinical problem-solving: unfashionably late. N Engl J Med. 2005;352:64-69.
31. LiPuma JJ. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr Opin Pulm Med. 1998;4:337-341.
32. Trujillo E, Herrero JI, Moyano C. Burkholderia cepacia pneumonia in a patient with common variable immunodeficiency [in Spanish]. Arch Bronconeumol. 2003;39:239-240.
33. Yamagishi Y, Fujita J, Takigawa K, et al. Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients. Chest. 1993;103:1706-1709.
34. Mitomi H, Mikami T, Takahashi H, et al. Colitis in chronic granulomatous disease resembling Crohn's disease: comparative analysis of CD68-positive cells between two disease entities. Dig Dis Sci. 1999;44:452-456.
35. Schappi MG, Smith VV, Goldblatt D, et al. Colitis in chronic granulomatous disease. Arch Dis Child. 2001;84:147-151.
36. Margolis DM, Melnick DA, Alling DW, et al. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis. 1990;162:723-726.
37. Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348:2416-2422.
38. The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of Interferon γ to prevent infection in chronic granulomatous disease. N Engl J Med 1991;324:509-516.
39. Leung T, Chik KW, Li CK, et al. Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature. Bone Marrow Transplant. 1999;24: 567-570.
40. Malech HL, Maples PB, Whiting-Theobald N, et al. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci USA. 1997;94:12133-12138.